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Abstract 
  BACKGROUND: Atherosclerosis, which is a result of gradual deposition of lipids in the lower 
part of blood vessel endothelium, is the leading cause of mortality and morbidity around the 
world. It has been proved that some inflammatory blood markers such as fibrinogen can predict 
the risk for cardiovascular disease conditions, not only in cardiovascular patients, but also in 
those who do not have any manifestations of the atherosclerotic development. In this study, the 
effect of cornus mas L. was evaluated on fibrinogen of hypercholesterolemic rabbits and it was 
also compared with lovastatin drug. 
 METHODS:  In this study, 25 New Zealand adult male rabbits were randomly divided into five 
groups of five. They were treated for 60 days by 5 different diets, namely basic, high cholesterol, 
regular plus 1 g/kgBW cornus mas L. powder, high cholesterol plus 1 g/kgBW cornus mas L. 
powder, and high cholesterol plus 10 mg/kgBW lovastatin. At the beginning and at the end of 
this period, blood samples were collected from the rabbits and their serum fibrinogen levels 
were measured. 
 RESULTS: Cornus mas L. powder and lovastatin significantly decreased fibrinogen levels in 
comparison with high cholesterol group (P < 0.05). Furthermore cornus mas L. powder could 
reduce the fibrinogen level more than lovastatin (P < 0.05). 
  CONCLUSION: The results indicated that consumption of cornus mas L. might be beneficial in 
atherosclerotic patients due to its reducing effects on fibrinogen. 
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Introduction 
Atherosclerosis and its side effects are among the ma-
jor mortality causes in the world.1 Research shows 
that homeostatic systems play an important role in 
pathogenesis of atherosclerosis vascular disease.2,3 
  Fibrinogen is linked with cardiovascular diseases 
via the two processes of inflammation and thrombo-
sis, which are the two major processes in the progress 
of atherosclerosis.4 
  Similar to C-reactive protein (CRP), fibrinogen is 
an acute phase reactor, which is more likely to be an 
inflammatory symptom rather than having a role in 
pathogenesis of coronary events. Fibrinogen synthesis 
in liver can increase up to four times during an in-
flammatory reaction or infection. In addition to in-
flammation, a number of other factors are also known 
as fibrinogen level regulators. Fibrinogen levels are 
higher in diabetes and hypertension patients, and also 
among obese people, or those with low physical activ-
ity lifestyles.5 Moreover, fibrinogen levels increase as 
low density lipoprotein (LDL) or a lipoprotein (LP 
(a)) levels rise; its level is also higher in smokers.6 
  Along with coagulation, fibrinogen has other dif-
ferent functions through which it can act as a cause 
for cardiovascular diseases, including atherosclerosis. 
These functions are as follow: 
1.  Regulation of cell (including vascular smooth 
muscle cells) adherence, chemotaxis, and repro-
duction 
2.  Arterial contraction in atherosclerotic injury sites COMPARING THE EFFECTS OF LOVASTATIN AND CORNUS MAS FRUIT ON FIBRINOGEN LEVEL  
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3.  Determining blood fluidity and density (blood ad-
herence)5,7 
  Although contrasting reports exist about fibrino-
gen changes in statin therapy, some researches suggest 
that lipid reduction medications, such as statins, can 
reduce the harmful cholesterol level in the body, but 
have a little effect on the reduction of fibrinogen lev-
el, as a cardiovascular disease risk factor.8 Further-
more, the side effects of these medications9,10 are oth-
er reasons to search for effective herbal compounds. 
Cornelian cherry, scientifically named cornus mas L., 
grows in different parts of Europe and Asia, including 
Iran. The fruit is full of glucose, fructose, lactose, or-
ganic acids and tannin. It also contains different kinds 
of antioxidant compounds, including flavonoids, an-
tosianins, anthocyanin, and many vitamins.11-13 
  Having the qualities of cornus mas L. in mind and 
knowing that fibrinogen is considered as a risk factor 
for atherosclerosis development, and also based on 
previous studies about anti-inflammatory and antith-
rombotic effects of flavonoid compounds, we have 
decided to examine the effectiveness of cornus mas L. 
fruit on hyperfibrinogenemia in hypercholesterolemic 
rabbits with a high cholesterol diet. 
Materials and Methods 
Cornus mas L. was purchased at the fruit market, and 
the quality and species of it were determined by a bo-
tanist in a herbarium in Shahrekord's medicinal plants 
center. After the fruits were washed and their seeds 
were removed, they were dried for 1 month and final-
ly used as a powder. 
 
Measurement of the effective components in 
phenolic extracts 
Total phenol content was determined using Folin-
Ciocalteu reagent method in terms of gallic acid. Total 
flavonoid and flavonol contents were calculated in 
terms of rutin, using a method suggested by Pourmo-
rad et al (2006) and a method suggested by Loziene et 
al,14,15 respectively. 
 
Categorizing and treating the rabbits 
Twenty five adult male New Zealand rabbits, weigh-
ing 2-2.5 kg, were purchased from Razi institution in 
Karaj and were transported to Shahrekord medicine 
school. The rabbits were held in standard light and 
temperature and were treated with basic diet for 2 
weeks in order to adapt them to the new environ-
ment. 
  The rabbits were then randomly categorized into 5 
groups of 5. They were treated as follows for 60 days: 
the first group with a basic diet, the second with a 
high cholesterol (1 %) diet, the third with a basic diet 
containing cornus mas L. powder (1 g/kgBW daily) 
diet, the forth with a high cholesterol (1%) containing 
cornus mas L. powder (1 g/kgBW daily) diet, and the 
fifth with a high cholesterol containing lovastatin (10 
mg/kgBW daily) diet. 
  During this 60-day period, the rabbits could freely 
access the food and water. Cornus mas L. powder (1 
g/kgBW) was fed to rabbits using gavage, along with 
5 cc water. 
  In high cholesterol diets, cholesterol made by 
Merc factory in Germany was gavage fed to the rab-
bits. 
 
Measurement of biochemical factors 
Before starting the diets and after the period of the 
study, the rabbits were fasting for 12 hours. Then, a 
blood sample was taken and the plasma was used to 
examine the fibrinogen factor. 
Fibrinogen was measured by means of a Mahsayaran 
kit, using coagulative method.  
 
Statistical analysis 
The results have been statistically analyzed in the form 
of mean ± SD. In order to examine the biochemical 
results and to compare the mean values for different 
experimental groups, ANOVA test and SPSS15 soft-
ware were used. P < 0.05 was considered as significant. 
The graph was drawn by Excel software. 
Results 
Each 100 g of cornus mas L. powder yielded 11 ± 0.4 
g ethanolic extract. The calculated levels for flavono-
id, flavonol, and phenol were 17.98 ± 1.9 mg/g, 
11.13 ± 5.80 mg/g, and 215.56 ± 2.88 mg/g, respec-
tively. 
  The mean values for biochemical factors among 
the five groups did not have any significant difference 
at the beginning of the period (Figure 1). As the graph 
shows, the high cholesterol diet resulted in a signifi-
cant increase in the density of fibrinogen, compared 
to the basic diet (P < 0.05). Moreover, treating the 
rabbits having a high cholesterol diet with cornus mas 
L. powder or lovastatin caused a significant reduction 
in fibrinogen, as compared with the basic high choles-
terol diet (P < 0.05). The fibrinogen level in the group 
receiving the basic diet containing cornus mas L. had 
an insignificant reduction compared to the group 
receiving the basic diet. An insignificant reduction in 
fibrinogen level was also observed when the high 
cholesterol diet containing cornus mas L. was 
compared with the high cholesterol diet containing 
lovastatin.  S. Asgary, M. Rafieian-Kopaei, A. Adelnia, S. Kazemi, F. Shamsi 
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Figure 1. The effects of cornus mas L. (CM) fruit and lovastatin on serum fibrinogen level in hypercholesterolic rabbits (the 
data is presented as mean ± SD, the study type was experimental) 
* The significant difference between the mean value of fibrinogen in high cholesterol and basic groups (P < 0.05) 
** The significant difference between the mean value of fibrinogen in high cholesterol + interventional treatment and high 
cholesterol groups 
*** The significant difference between the mean value of fibrinogen at the beginning and at the end of the period of study 
in each group 
 
Discussion 
The results obtained from this study indicate that in 
high cholesterol diets, cornus mas L. and lovastatin 
can reduce the fibrinogen level. 
  Fibrinogen is an inflammatory and coagulation 
risk factor and has an important role in the complexi-
ty of atherosclerosis process.16 The enforcement of 
platelet aggregation and formation of fibrin coagulum 
are among the primary functions of fibrinogen during 
homeostasis process in the arterial injury site.17 It has 
been reported that fibrinogen oxidation and its fibri-
nolyze residuals stimulate platelet aggregation and IL-
6 increment,16 and therefore the reducing effects of 
cornus mas L. on fibrinogen levels can be due to the 
participation of its components in inflammatory or 
coagulative processes. 
  There have been studies showing the effects of 
herbal diets on the processes of inflammation and 
fibrinolyze. These compounds are effective in the 
reduction of coagulative factors, or the augmenta-
tion of fibrinolyze via reducing blood coagulation by 
means of decreasing fibrinogen levels, increasing 
fibrinolyze and prothrombin time, and also prevent-
ing platelet aggregation.18,19 The anti-inflammatory 
and arterial protective effects20 of anthocyanins, 
which are among the most important antioxidants in 
cornus mas L. fruit,21,22 along with their usefulness in 
the excretion of free radicals, have been investi-
gated.8,23,24 
  Research shows that the consumption of antioxi-
dants will increase the antioxidantal capacity and de-
crease cardiovascular disease development chance, 
and also the risk associated with raised fibrinogen 
level.25 As a result, it is probably true that the antioxi-
dant compounds in cornus mas L. fruit, including 
vitamins and phenolic compounds, would prevent 
free radical action and fibrinogen oxidation and its 
fibrinolyze residuals, which stimulate platelet aggrega-
tion and increase inflammatory cytokines. 
  Inflammation and platelet aggregation will increase 
fibrinogen production in the liver by 4 times. On the 
other hand, Fibrinogen level increases in response to 
interleukins 1 and 6 (cytokines produced in arterial 
disorders).26 Evidence suggests that the bare matrix 
under an injured endothelium contains a great 
amount of pre-coagulation compounds, including 
collagen. In the process of absorption and activation 
of platelets, collagen acts like a ligand. In other words, 
just like a strong antagonist, collagen causes the re-
lease of platelet granules and the presentation of ac-
tive ligands, such as IIb- IIIa. Platelet granules contain 
VWF (Von Willebrand Factor) and fibrinogen which 
act as a connecting bridge between the collagen under 
endothelium and glycoprotein platelet receptor 
(GPTb). The process of platelet aggregation contin-
ues as fibrinogen connects a big number of platelets 
to each other via GPIIb-IIIa platelet receptors.27 Re-
search shows that in the inflammation and arterial 
wall injury site, anthocyanins and anthocyanidins af-
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fect the structure and metabolism of collagen and 
cause stronger collagen fibers and better crosslink 
among them (via affecting proline hydroxylase en-
zyme), and actually prevent collagens from attaching 
to platelets in the primary stages of inflammation and 
arterial injury.28 In addition, anthocyanic extract stops 
inflammation, and thus atherosclerosis progress, by 
preventing elastase enzyme (a collagen destructive 
enzyme) from action.29 It has been observed that po-
lyphenols existing in cocoa reduce the inflammatory 
cytokinines and inhibit platelet activity and epineph-
rine gene (a platelet aggregation agonist that is pro-
duced at platelet aggregation site) expression and also 
glycoprotein IIa/IIIbv on the platelet surface; in addi-
tion, they reduce P-Selection expression (as an in-
flammatory agent).30 
  Research shows that delphinidin and pelargonin 
glycosides, existing in cornus mas L. fruit, inhibit cyc-
looxygenase inflammatory enzymes activity31,32 and 
therefore reduce the levels of pre-inflammatory com-
pounds and cytokinines. Recent studies have demon-
strated that polyphenols such as catechin and querce-
tin, stop NADPH oxidase enzyme (existing in plate-
lets), thus inhibiting the production of O2¯ and in-
creasing the biological power of NO, and consequent-
ly regulate the glycoprotein pine receptors on platelet 
membrane surface (GPIIb-IIIa) which in turn inhibits 
the platelets activation and their adherence during the 
inflammation and thrombosis processes 33. 
  Consumption of lovastatin has also led to a reduc-
tion in fibrinogen level compared to the high choles-
terol group. 
  Statins are a group of antihyperlipidemic com-
pounds and anti-inflammatory effects are amongst 
their most important pleiotropic qualities. These ef-
fects are due to the ability of statins in preventing 
mevolonic acid formation, whose reduction results in 
a decrease in cholesterol level and some other isopre-
noid inflammatory mediators.34 It was also observed 
that in hyperlipidemic patients, statins reduce the 
platelet adhesive molecules, ICAM-1 and P-Selection; 
they also decrease MCP-1 expression, interleukins 1 
and 6 production, and oxygenase-2 cycle gene expres-
sion in human endothelial cells.35-37 In fact, statins 
reduce platelet clot and cardiovascular diseases via 
decreasing inflammatory agents and affecting 
homeostase process and NO production by 
endothelial cells.38,39 
Conclusion 
In basic and high cholesterol diets, cornus mas L. 
powder consumption results in fibrinogen level 
reduction which is an indicator of this fruit's anti-
inflammatory and anticoagulative effects. The 
effectiveness of this fruit on the mentioned 
biochemical parameter equals to (or even surpasses) 
lovastatin with a dose of 10 mg. Considering the use-
fulness of cornus mas L. on reducing fibrinogen 
(which is an important inflammatory or coagulative 
agent, and also a major risk factor for cardiovascular 
diseases), further investigations on this subject seem 
necessary. 
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